Matinas BioPharma Inc. (MTNB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Matinas BioPharma Inc.

    AMEX: MTNB · Real-Time Price · USD
    1.95
    0.01 (0.52%)
    At close: Oct 06, 2025, 11:39 AM

    Matinas BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 7.28M 4.79M 6.83M 21.03M
    Short-Term Investments
    		 n/a 8.97M 21.93M 28.59M
    Long-Term Investments
    		 200K n/a 200K n/a
    Other Long-Term Assets
    		 n/a 200K -34.05M 200K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 741K 50K 5.77M 50K
    Total Current Assets
    		 8.03M 15.54M 34.53M 50.99M
    Property-Plant & Equipment
    		 2.16M 5.01M 5.73M 5.78M
    Goodwill & Intangibles
    		 2.26M 4.35M 4.35M 4.35M
    Total Long-Term Assets
    		 4.62M 9.56M 10.29M 10.33M
    Total Assets
    		 12.64M 25.1M 44.82M 61.33M
    Account Payables
    		 95K 514K 618K 937K
    Deferred Revenue
    		 n/a n/a 721K 932K
    Short-Term Debt
    		 766K n/a 569K n/a
    Other Current Liabilities
    		 -762K 271K 825K 1.51M
    Total Current Liabilities
    		 2.67M 2.62M 4.29M 4.35M
    Long-Term Debt
    		 n/a n/a n/a 4.14B
    Other Long-Term Liabilities
    		 n/a n/a n/a -4.14B
    Total Long-Term Liabilities
    		 2.38M 3.24M 3.9M 4.48M
    Total Liabilities
    		 5.05M 5.86M 8.18M 8.83M
    Total Debt
    		 2.89M 3.56M 4.12M 4.7M
    Book Value
    		 7.59M 19.25M 36.64M 52.49M
    Book Value Per Share
    		 1.56 4.43 8.45 12.49
    Common Stock
    		 1K 22K 22K 21.63K
    Retained Earnings
    		 -199.82M -175.57M -152.63M -131.63M
    Comprehensive Income
    		 n/a -221K -824K -145.5K
    Shareholders Equity
    		 7.59M 19.25M 36.64M 52.49M
    Total Investments
    		 200K 8.97M 21.93M 28.59M

    Add to Watchlist